Thompson Siegel & Walmsley’s Hologic HOLX Stock Holding History

Thompson Siegel & Walmsley’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,531	Closed	-$267K	–	447
2026 Q1	$267K	Hold	3,531	–	–	﹤0.01%	399
2025 Q4	$263K	Hold	3,531	–	–	﹤0.01%	385
2025 Q3	$238K	Hold	3,531	–	–	﹤0.01%	389
2025 Q2	$230K	Hold	3,531	–	–	﹤0.01%	379
2025 Q1	$218K	Hold	3,531	–	–	﹤0.01%	374
2024 Q4	$255K	Hold	3,531	–	–	﹤0.01%	362
2024 Q3	$288K	Hold	3,531	–	–	﹤0.01%	355
2024 Q2	$262K	Hold	3,531	–	–	﹤0.01%	341
2024 Q1	$275K	Hold	3,531	–	–	﹤0.01%	339
2023 Q4	$252K	Hold	3,531	–	–	﹤0.01%	329
2023 Q3	$245K	Hold	3,531	–	–	﹤0.01%	332
2023 Q2	$286K	Hold	3,531	–	–	﹤0.01%	331
2023 Q1	$285K	Hold	3,531	–	–	﹤0.01%	329
2022 Q4	$264K	Sell	3,531 -200	-5%	-$14.2K	﹤0.01%	323
2022 Q3	$241K	Hold	3,731	–	–	﹤0.01%	331
2022 Q2	$259K	Hold	3,731	–	–	﹤0.01%	322
2022 Q1	$287K	Hold	3,731	–	–	﹤0.01%	345
2021 Q4	$286K	Hold	3,731	–	–	﹤0.01%	351
2021 Q3	$275K	Sell	3,731 -194	-5%	-$14.5K	﹤0.01%	345
2021 Q2	$262K	Hold	3,925	–	–	﹤0.01%	352
2021 Q1	$292K	Hold	3,925	–	–	﹤0.01%	331
2020 Q4	$286K	Hold	3,925	–	–	﹤0.01%	318
2020 Q3	$261K	Sell	3,925 -200	-5%	-$12.7K	0.01%	306
2020 Q2	$235K	Hold	4,125	–	–	﹤0.01%	313
2020 Q1	$145K	Hold	4,125	–	–	﹤0.01%	335
2019 Q4	$215K	Hold	4,125	–	–	﹤0.01%	371
2019 Q3	$208K	Hold	4,125	–	–	﹤0.01%	383
2019 Q2	$198K	Hold	4,125	–	–	﹤0.01%	393
2019 Q1	$200K	Hold	4,125	–	–	﹤0.01%	395
2018 Q4	$170K	Hold	4,125	–	–	﹤0.01%	386
2018 Q3	$169K	Hold	4,125	–	–	﹤0.01%	413
2018 Q2	$164K	Hold	4,125	–	–	﹤0.01%	425
2018 Q1	$154K	Hold	4,125	–	–	﹤0.01%	422
2017 Q4	$176K	Hold	4,125	–	–	﹤0.01%	428
2017 Q3	$151K	Hold	4,125	–	–	﹤0.01%	432
2017 Q2	$187K	Hold	4,125	–	–	﹤0.01%	428
2017 Q1	$176K	Hold	4,125	–	–	﹤0.01%	459
2016 Q4	$165K	Hold	4,125	–	–	﹤0.01%	420
2016 Q3	$160K	Sell	4,125 -51	-1%	-$1.93K	﹤0.01%	413
2016 Q2	$144K	Buy	4,176 +51	+1%	+$1.77K	﹤0.01%	404
2016 Q1	$142K	Sell	4,125 -876	-18%	-$30.5K	﹤0.01%	391
2015 Q4	$193K	Sell	5,001 -820	-14%	-$31.9K	﹤0.01%	371
2015 Q3	$228K	Sell	5,821 -320	-5%	-$12.7K	﹤0.01%	370
2015 Q2	$234K	Sell	6,141 -80	-1%	-$2.8K	﹤0.01%	374
2015 Q1	$205K	Sell	6,221 -298,111	-98%	-$9.15M	﹤0.01%	385
2014 Q4	$8.14M	Sell	304,332 -740	-0.2%	-$19.1K	0.15%	223
2014 Q3	$7.42M	Sell	305,072 -33,360	-10%	-$842K	0.15%	219
2014 Q2	$8.58M	Sell	338,432 -4,195	-1%	-$98K	0.17%	215
2014 Q1	$7.37M	Sell	342,627 -14,870	-4%	-$321K	0.17%	212
2013 Q4	$7.99M	Sell	357,497 -49,465	-12%	-$1.09M	0.19%	209
2013 Q3	$8.4M	Sell	406,962 -2,405	-0.6%	-$51.2K	0.18%	211
2013 Q2	$7.9M	Buy	+409,367	New	+$8.55M	0.17%	228

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Thompson Siegel & Walmsley's HOLX Position: Q2 2026 in Review

Thompson Siegel & Walmsley sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,531 shares — an estimated $267K sold.

Thompson Siegel & Walmsley first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $8.58M in Q2 2014. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Thompson Siegel & Walmsley reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Thompson Siegel & Walmsley sold 3,531 Hologic shares in Q2 2026, an estimated $267K.
Thompson Siegel & Walmsley first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
Thompson Siegel & Walmsley's Hologic position peaked at $8.58M in Q2 2014.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.